Watch Ticker

ProQR Therapeutics N.V. Ordinary Shares

Go to ProQR Therapeutics N.V. Ordinary Shares Website

$2.12

0.00 (0.00%)
Live
Previous Close

$2.115

Day Range

$0 - $0

Previous Day Range

$2.01 - $2.1451

Market Cap

$218.1 million USD

Day Vol.

0

Previous Day Vol.

172050

Currency

USD

Primary Exchange

Nasdaq

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The onl...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

ProQR Therapeutics reported its Q1 2025 financial results, highlighting progress in its Axiomer RNA editing pipeline, including the advancement of its lead program AX-0810 targeting NTCP for cholestatic diseases towards a CTA filing in Q2 2025. The company also strengthened its leadership team with new CFO and CMO appointments.

Related tickers: PRQR.

Read Full Article

ProQR Therapeutics is advancing its Axiomer™ ADAR-mediated RNA editing pipeline, with plans to file a CTA for its lead program AX-0810 targeting NTCP for Cholestatic diseases in Q2 2025. The company expects up to four clinical data readouts in 2025 and 2026, and has a strong financial position with €149.4 million in cash and cash equivalents as of the end of 2024.

Related tickers: PRQR, LLY.

Read Full Article
Trending Tickers

Please sign in to view